
The long-term outcome of patients in the LRF CLL4 trial: the effect …
With 10+ years follow-up in the Leukaemia Research Fund (LRF) CLL4 trial, we report the effect of salvage therapy, and the clinical/biological features of the 10-year survivors treated for chronic lymphocytic leukaemia (CLL). Overall survival (OS) was similar in the three randomized arms.
四氯化碳(化学物质)_百度百科
四氯化碳(carbon tetrachloride,可缩写为CTC), 化学式 为CCl4,是甲烷的四个 氢原子 都被 氯 原子取代而成的全 卤代烃 (有机化合物),故又名 四氯甲烷,为无色透明、有臭味/芳香气味、易挥发的液体,微溶于水,易溶于 醇 、 醚 、 石油醚 、 氯仿 等 有机溶剂,被广泛用作 有机溶剂 、 制冷剂 、有机合成原料、 干洗剂 等 [103-104]。 该物质可经吸入、经皮肤和经食入被吸收到体内,短期接触会刺激眼睛,可能对 肝脏 、 肾脏 和 中枢神经 系统造成影响,可能导致意识不 …
Quality of life in chronic lymphocytic leukemia: 5-year ... - PubMed
Health-related quality of life (HRQoL) is a key issue for patients with chronic lymphocytic leukemia. The multicenter LRF CLL4 trial, in which 777 patients were randomized to receive chlorambucil or fludarabine, alone or with cyclophosphamide (FC), assessed HRQoL at baseline, months 3, 6 and 12, the …
Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; …
In chronic lymphocytic leukemia (CLL), ‘coding' NOTCH1 mutations were initially detected in exon 34 where they result in truncation of the C-PEST regulatory protein sequence with consequent impaired degradation of the Notch1 intracellular domain (NCID), constitutive activation of Notch signalling and increased cell survival and resistance to apo...
四氯化碳 - 搜狗百科
2024年12月5日 · 四氯化碳(carbon tetrachloride),有机化合物,化学式CCl4,是一种无色有毒液体,能溶解脂肪、油漆等多种物质,易挥发液体,具氯仿的微甜气味。 四氯化碳与水互不相溶,可与 乙醇 、乙醚等混溶。 2017年10月27日,世界卫生组织国际癌症研究机构公布的致癌物清单初步整理参考,四氯化碳在2B类致癌物清单中。 1、摩尔折射率:26.04. 2、摩尔体积(cm3/mol):90.6. 3、等张比容(90.2K):220.7. 4、表面张力(dyne/cm):35.2. 5、极 …
The prognostic significance of a positive direct antiglobulin test in ...
2008年2月15日 · Autoimmune hemolytic anemia (AHA) is a common complication in chronic lymphocytic leukemia (CLL). The UK LRF CLL4 trial is the largest prospective trial in CLL to examine the prognostic impact of both a positive direct antiglobulin test (DAT) and AHA.
Mutational Status of the TP53 Gene As a Predictor of Response …
2011年4月11日 · We analyzed 529 CLL samples from the LRF CLL4 (Leukaemia Research Foundation Chronic Lymphocytic Leukemia 4) trial (chlorambucil v fludarabine with or without cyclophosphamide) at the time of random assignment for mutations in the TP53 gene. TP53 mutation status was correlated with response and survival data.
The morphology of CLL revisited: the clinical significance of ...
This study re‐examines the biological and clinical significance of increased peripheral blood prolymphocytes in 508 patients at entry into the randomized UK Leukaemia Research Fund CLL4 trial.
四氯化碳中毒 - 百度百科
四氯化碳 (carbon tetrachloride,CCl4)为无色液体,是工业生产中良好的溶剂,也用作干洗剂、灭火剂及薰蒸剂。 CCl4遇火焰或灼热金属表面,可分解为 光气 和 氯化氢,毒性增加。 CCl4及其分解产物可经呼吸道吸收,皮肤接触吸收也快。 在体内代谢迅速,吸入后约50%以原形自肺排出,20%在体内氧化转化,最终产物为二氧化碳。 CCl4对 中枢神经系统 有 麻醉 作用,也损害周围神经,但较突出的是肝损害。 CCl4在 肝细胞 内质网经羟化酶作用,产生 自由基 -C·C l3,发 …
Early Results from LRF CLL4: A UK Multicenter Randomized Trial.
2005年11月16日 · CLL4 has generated a wealth of prognostic information: FISH, VH mutations, expression of CD38 and ZAP-70 which will allow a better characterization of risk groups and their response to first-line therapy. Some of these analyses …